ATRA (Atara Bio) Short-Term Debt to Capital
Atara Biotherapeutics (ATRA) develops advanced methods for combating oncology and autoimmune disorders. This daily price chart confirms the technological superiority of the Ebvallo platform within the biotechnology sector. Revenue is generated through the supply of high-cost cell therapies to specialized clinics and insurance structures. The current figure stands at 0.00. Competitiveness is sustained by patents for multiple sclerosis therapy, despite significant research and development expenditures.
Analytical breakdowns for Atara Biotherapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Atara Biotherapeutics|ATRA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Atara Biotherapeutics|ATRA - Aggregate Debt Obligations|Debts to Book Capitalization Atara Biotherapeutics, Inc.|ATRA - Long-Term Debt Volume|Company Short-Term Debt Atara Biotherapeutics|Quick Liquidity atarabio.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Atara Bio
This ratio measures the proportion of short-term liabilities relative to equity, determining the company's dependence on rapid liquidity and the risk of default. By analyzing the short-term liabilities-to-equity ratio, an investor assesses the balance between financial stability and expansion rates, which is critical for Atara Biotherapeutics (ATRA) during the market launch of Ebvallo and the scaling of allogeneic T-cell therapies.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN - Short-Term Debt to Capital|PVLA (Pieris Pharmaceuticals) - Short-Term Debt to Equity Ratio|SVRA: Short-Term Loans to Capital Ratio|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital AnaptysBio Inc|Short-Term Debt to Equity Astria Pharma (ATXS)|ENGN (enGene Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital KYTX (Kyverna Therapeutics Inc.)|TLSA: Short-Term Debt to Capital|CABA (Cabaletta Bio Inc) - Short-Term Debt to Equity|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|theratech.com (THTX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Avalo Therapeutics (AVTX)|ELDN - Current Liabilities to Capital|Agenus Inc - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CLYM (Climb Bio, Inc)|Zura Bio - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital ATYR (atyrpharma.com)|ADAG: Short-Term Debt to Capital|Current Liabilities to Capital Ikena Oncology (IMA)|Short-Term Debt to Equity Shattuck Labs Inc|EQ: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CNTB|Short-Term Debt to Capital immunic-therapeutics.com (IMUX)|Short-Term Debt to Equity InflaRx IFRX|XFOR (X4 Pharmaceuticals Inc.) - Current Liabilities to Equity|Adicet - Short-Term Debt to Capital|Current Liabilities to Capital Celularity Inc.|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|barinthusbio.com (BRNS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio KZR|SABS (SAB Biotherapeutics Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Capital QTTB (Q32 Bio)|GOVX - Short-Term Debt to Equity Ratio|EDSA - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient iBio Inc IBIO|CARM: Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio BOLT|HCWB (HCW Biologics Inc) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|Current Liabilities to Equity HIND|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Affimed (AFMD)|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS - Short-Term Debt to Equity Ratio|iTeos - Short-Term Debt to Capital|OCEA - Short-Term Debt to Capital|TCBP (TC Biopharm) - Short-Term Debt to Equity Ratio|thirdharmonicbio.com - Ratio of Short-Term Indebtedness to Capital